___

[1] E. L. Decker and R. Reski, "Mosses in biotechnology," Curr Opin Biotechnol, vol. 61, pp. 21-27, Feb 2020, doi: 10.1016/j.copbio.2019.09.021.

[2] A. Alam, "Some Indian bryophytes known for their biologically active compounds," International Journal of Applied Biology and Pharmceutical Technology, vol. 3, no. 2, pp. 239-246, 2012.

[3] Y. Asakawa, "Biologically active compounds from bryophytes," (in English), Pure and Applied Chemistry, vol. 79, no. 4, pp. 557-580, Apr 2007, doi: 10.1351/pac200779040557.

[4] A. S. Lubaina, D. P. Pradeep, J. M. Aswathy, Remya Krishnan M. K. V., and Murgan K., "Traditional knowledge of medicinal bryophytes by the kani tribes of Agasthiyarmalai biosphere reserve, southern western ghats," Indo American Journal of Pharmaceutical Research, vol. 4, pp. 2116-2121, 2014.

[5] A. G. Azuelo, L. G. Sariana, and M. P. Pabualan, "Some Medicinal Bryophytes: their Ethnobotanical Uses and Morphology," Asian Journal of Biodiversity, vol. 2, no. 1, 2011/12/01 2011, doi: 10.7828/ajob.v2i1.92.

[6] J. M. Glime, "Economic and ethnic uses of bryophytes," Flora of North America, vol. 27, pp. 14-41, 2007.

[7] A. Gulabani, "Bryophytes as economic plants," Botanica, 1974.

[8] J. M. Forbes and A. K. Fotheringham, "Vascular complications in diabetes: old messages, new thoughts," Diabetologia, vol. 60, no. 11, pp. 2129-2138, Nov 2017, doi: 10.1007/s00125-017-4360-x.

[9] J. Chaudhuri et al., "The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality," Cell Metab, vol. 28, no. 3, pp. 337-352, Sep 4 2018, doi: 10.1016/j.cmet.2018.08.014.

[10] R. Singh, H. K. Rao, and T. G. Singh, "Advanced glycated end products (ages) in diabetes and its complications: an insight," Plant Archives, vol. 20, no. 1, pp. 3838- 3841, 2020.

[11] C. A. Emdin, S. G. Anderson, M. Woodward, and K. Rahimi, "Usual Blood Pressure and Risk of New-Onset Diabetes: Evidence From 4.1 Million Adults and a Meta-Analysis of Prospective Studies," J Am Coll Cardiol, vol. 66, no. 14, pp. 1552-1562, Oct 6 2015, doi: 10.1016/j.jacc.2015.07.059.

[12] D. Kajaria, Ranjana, J. Tripathi, Y. B. Tripathi, and S. Tiwari, "In-vitro alpha amylase and glycosidase inhibitory effect of ethanolic extract of antiasthmatic drug - Shirishadi," (in eng), J Adv Pharm Technol Res, vol. 4, no. 4, pp. 206-9, Oct 2013, doi: 10.4103/2231-4040.121415.

[13] N. Xu, S. Jiang, P. B. Persson, E. A. G. Persson, E. Y. Lai, and A. Patzak, "Reactive oxygen species in renal vascular function," Acta Physiol (Oxf), https://doi.org/10.1111/apha.13477 vol. 229, no. 4, p. e13477, Aug 2020, doi: 10.1111/apha.13477.

[14] T. Senoner and W. Dichtl, "Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?," Nutrients, vol. 11, no. 9, Sep 4 2019, doi: 10.3390/nu11092090.

[15] C. L. Curl, M. Spivak, R. Phinney, and L. Montrose, "Synthetic Pesticides and Health in Vulnerable Populations: Agricultural Workers," Curr Environ Health Rep, vol. 7, no. 1, pp. 13-29, Mar 2020, doi: 10.1007/s40572-020-00266-5.

[16] E. K. Kocazorbaz, R. N. Un, A. Erdag, and F. Zihnioglu, "Inhibitory Effects of Some Bryophytes on Glutathione-S - Transferase," Current Enzyme Inhibition, vol. 13, no. 1, pp. 34-40, 2017/02/02 2017, doi: 10.2174/1573408012666160628081431.

[17] V. L. Singleton, R. Orthofer, and R. M. Lamuela-Raventós, "[14] Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent," in Oxidants and Antioxidants Part A, ed: Elsevier, 1999, pp. 152-178.

[18] A. Arvouet-Grand, B. Vennat, A. Pourrat, and P. Legret, "[Standardization of propolis extract and identification of principal constituents]," (in fre), Journal de pharmacie de Belgique, vol. 49, no. 6, pp. 462-8, Nov-Dec 1994. [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/788 4635. Standardisation d'un extrait de propolis et identification des principaux constituants.

[19] R. Apak, K. Guclu, M. Ozyurek, S. E. Karademir, and M. Altun, "Total antioxidant capacity assay of human serum using copper(II)-neocuproine as chromogenic oxidant: the CUPRAC method," Free Radic Res, vol. 39, no. 9, pp. 949-61, Sep 2005, doi: 10.1080/10715760500210145.

[20] X. Li, X. Wang, D. Chen, and S. Chen, "Antioxidant Activity and Mechanism of Protocatechuic Acid in vitro," Functional Foods in Health and Disease, vol. 1, no. 7, p. 232, 2011/07/31 2011, doi: 10.31989/ffhd.v1i7.127.

[21] A. Zeytunluoglu and F. Zihnioglu, "Evaluation of some plants for potential dipeptidyl peptidase IV inhibitory effects in vitro," (in English), Turkish Journal of Biochemistry-Turk Biyokimya Dergisi, vol. 40, no. 3, pp. 217-223, 2015/01/01 2015, doi: 10.1515/tjb.2015.0004.

[22] T. Matsui, C. Yoshimoto, K. Osajima, T. Oki, and Y. Osajima, "In vitro survey of alpha-glucosidase inhibitory food components," Biosci Biotechnol Biochem, vol. 60, no. 12, pp. 2019-22, Dec 1996, doi: 10.1271/bbb.60.2019.

[23] H. K. Kani, E. K. Kocazorbaz, and F. Zihnioglu, "Investigation and isolation of peptide based antiglycating agents from various sources," (in English), Turkish Journal of Biochemistry-Turk Biyokimya Dergisi, vol. 44, no. 5, pp. 699-705, Oct 2019, doi: 10.1515/tjb-2018-0294.

[24] C. F. Xie and H. X. Lou, "Secondary metabolites in bryophytes: an ecological aspect," Chem Biodivers, vol. 6, no. 3, pp. 303-12, Mar 2009, doi: 10.1002/cbdv.200700450.

[25] X. Wang, J. Cao, X. Dai, J. Xiao, Y. Wu, and Q. Wang, "Total flavonoid concentrations of bryophytes from Tianmu Mountain, Zhejiang Province (China): Phylogeny and ecological factors," (in eng), PLoS One, vol. 12, no. 3, p. e0173003, 2017, doi: 10.1371/journal.pone.0173003.

[26] Y. H. Wu, H. Y. Yang, H. Luo, and Q. Gao, "Resources of medicinal bryophytes in north--eastern China and their exploitation," Chinese Journal of Ecology, vol. 23, no. 5, pp. 218-223, 2004.

[27] M. Atanassova, S. Georgieva, and K. Ivancheva, "Total phenolic and total flavonoid contents, antioxidant capacity and biological contaminants in medicinal herbs," Journal of the University of Chemical Technology Metallurgy, vol. 46, no. 1, 2011.

[28] J. G. Cao, Y. X. Zheng, X. Xia, Q. X. Wang, and J. B. Xiao, "Total flavonoid contents, antioxidant potential and acetylcholinesterase inhibition activity of the extracts from 15 ferns in China," (in English), Industrial Crops and Products, vol. 75, pp. 135-140, Nov 30 2015, doi: 10.1016/j.indcrop.2015.04.064.

[29] N. Saeed, M. R. Khan, and M. Shabbir, "Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L," (in eng), BMC Complement Altern Med, vol. 12, p. 221, Nov 16 2012, doi: 10.1186/1472-6882- 12-221.

[30] X. Xia, J. G. Cao, Y. X. Zheng, Q. X. Wang, and J. B. Xiao, "Flavonoid concentrations and bioactivity of flavonoid extracts from 19 species of ferns from China," (in English), Industrial Crops and Products, vol. 58, pp. 91-98, Jul 2014, doi: 10.1016/j.indcrop.2014.04.005.

[31] B. Aslanbaba, S. Yilmaz, Ö. TonguÇ YayintaŞ, D. ÖZyurt, and B. DemİRata ÖZtÜRk, "Total Phenol Content and Antioxidant Activity of Mosses from Yenice Forest (Ida Mountain)," Journal of Scientific Perspectives, vol. 1, no. 1, pp. 1- 12, 2017/09/01 2017, doi: 10.26900/jsp.2017.0.

[32] S. Sethi, A. Joshi, B. Arora, A. Bhowmik, R. R. Sharma, and P. Kumar, "Significance of FRAP, DPPH, and CUPRAC assays for antioxidant activity determination in apple fruit extracts," (in English), European Food Research and Technology, vol. 246, no. 3, pp. 591-598, Mar 2020, doi: 10.1007/s00217-020-03432-z.

[33] S. R. Lin et al., "The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo," (in eng), Ther Adv Chronic Dis, vol. 10, p. 2040622319875305, 2019, doi: 10.1177/2040622319875305.

[34] D. Sharma, S. Kumar, S. Kumar, and D. Kumar, "DPP-IV Inhibitors from natural sources: An alternative approach for treatment and management of diabetes," (in English), Indian Journal of Natural Products and Resources, vol. 10, no. 4, pp. 227-237, Dec 2019. [Online]. Available: ://WOS:000573214800001.

[35] K. G. P. Wasana, A. P. Attanayake, K. A. P. W. Jayatilaka, and T. P. Weerarathna, "Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus," (in English), Journal of Complementary Medicine Research, vol. 11, no. 1, pp. 43-53, 2020, doi: 10.5455/jcmr.2020.11.01.06.

[36] T. M. Lunic et al., "Extracts Characterization and In Vitro Evaluation of Potential Immunomodulatory Activities of the Moss Hypnum cupressiforme Hedw," (in eng), Molecules, vol. 25, no. 15, p. 3343, Jul 23 2020, doi: 10.3390/molecules25153343.

[37] J. Fan, M. H. Johnson, M. A. Lila, G. Yousef, and E. G. de Mejia, "Berry and Citrus Phenolic Compounds Inhibit Dipeptidyl Peptidase IV: Implications in Diabetes Management," (in eng), Evid Based Complement Alternat Med, vol. 2013, p. 479505, 2013, doi: 10.1155/2013/479505.

[38] P. Kalhotra, V. Chittepu, G. Osorio-Revilla, and T. Gallardo-Velazquez, "Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus," (in eng), Biomolecules, vol. 10, no. 2, p. 305, Feb 14 2020, doi: 10.3390/biom10020305.

[39] C. H. Peng, Y. S. Yang, K. C. Chan, C. J. Wang, M. L. Chen, and C. N. Huang, "Hibiscus sabdariffa polyphenols alleviate insulin resistance and renal epithelial to mesenchymal transition: a novel action mechanism mediated by type 4 dipeptidyl peptidase," J Agric Food Chem, vol. 62, no. 40, pp. 9736-43, Oct 8 2014, doi: 10.1021/jf5024092.

[40] M. Zaklos-Szyda, A. Kowalska-Baron, N. Pietrzyk, A. Drzazga, and A. Podsedek, "Evaluation of Viburnum opulus L. Fruit Phenolics Cytoprotective Potential on Insulinoma MIN6 Cells Relevant for Diabetes Mellitus and Obesity," (in eng), Antioxidants (Basel), vol. 9, no. 5, p. 433, May 16 2020, doi: 10.3390/antiox9050433.

[41] L. A. Malik, G. M. Aziz, and A. H. Ad'hiah, "The Potential of some Plant Extracts as Radical Scavengers and Dipeptidyl Peptidase-4 Inhibitors," (in English), Baghdad Science Journal, vol. 16, no. 1, pp. 162-168, 2019/03/17 2019, doi: 10.21123/bsj.2019.16.1(Suppl.).0162.

[42] B. A. R. Sukma, D. Indarto, and Y. H. Suselo, "Inhibition effect of Cuscuta australis ethanol extract containing actinodaphnine on dipeptidyl peptidase-4 enzyme activity in the MCF-7 cell line," presented at the AIP Conference Proceedings 2021, 030003, 2018. [Online]. Available: http://dx.doi.org/10.1063/1.5062727.

[43] G. Turdu, H. Gao, Y. Jiang, and M. Kabas, "Plant dipeptidyl peptidase-IV inhibitors as antidiabetic agents: a brief review," Future Med Chem, vol. 10, no. 10, pp. 1229-1239, May 1 2018, doi: 10.4155/fmc-2017-0235.

[44] P. McCue, Y. I. Kwon, and K. Shetty, "Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean," (in eng), Asia Pacific journal of clinical nutrition, vol. 14, no. 2, pp. 145-52, 2005. [Online]. Available: https://www.ncbi.nlm.nih.gov/pubmed/159 27931.

[45] F. Rahim et al., "Synthesis, in vitro alphaglucosidase inhibitory potential of benzimidazole bearing bis-Schiff bases and their molecular docking study," Bioorg Chem, vol. 94, p. 103394, Jan 2020, doi: 10.1016/j.bioorg.2019.103394.

[46] T. Q. Tran, H. N. Phan, A. L. Bui, and P. D. D. Quach, "Biological activities of in vitro liverwort Marchantia polymorpha L. extracts," (in English), Notulae Botanicae Horti Agrobotanici Cluj-Napoca, vol. 48, no. 2, pp. 826-838, Apr-Jun 2020, doi: 10.15835/nbha48211884.

[47] D. Pant, B. Aryal, D. Pun, S. Sharma, and G. P. Joshi, "Inhibition of a-amylase and aglucosidase activities in vitro by extracts of selected medicinal plants," Biodiversitas Journal of Biological Diversity, vol. 22, no. 3, 2021/02/11 2021, doi: 10.13057/biodiv/d220314.

[48] N. A. Ansari and Z. Rasheed, "Nonenzymatic glycation of proteins: From diabetes to cancer," Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, vol. 3, no. 4, pp. 335-342, 2009/11/17 2009, doi: 10.1134/s1990750809040027.

[49] S. Mukhia, P. Mandal, D. K. Singh, and D. Singh, "Evaluation of anti-diabetic, antioxidant activity and phytochemical constituents of liverworts of easternhimalaya," Journal of Chemical and Pharmaceutical Research, vol. 7, pp. 890- 900, 01/01 2015.

[50] J. J. Park and W. Y. Lee, "Anti-glycation effects of brown algae extracts and its phenolic compounds," Food Bioscience, vol. 41, p. 101042, 2021/06 2021, doi: 10.1016/j.fbio.2021.101042